William E. P. Renwick
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Alpha E. Tsui (1 shared paper)Sant‐Rayn Pasricha (1 shared paper)Daniel Steinfort (1 shared paper)Matthew Conron (1 shared paper)Louis B. Irving (1 shared paper)Phillip N. Antippa (1 shared paper)Ruth Pettengell (1 shared paper)James Tatoulis (1 shared paper)
- Journals
- Blood (8 papers)Leukemia (2 papers)The Lancet (1 paper)BioDrugs (1 paper)The Annals of Thoracic Surgery (1 paper)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
William E. P. Renwick
17 papers receiving 1.1k citations
William E. P. Renwick's Hit Papers
Peers
Comparison fields: 5 of 58
- Pathology and Forensic Medicine 467
- Hematology 251
- Geriatrics and Gerontology 27
- Biochemistry 44
- Genetics 44
Countries citing papers authored by William E. P. Renwick
This map shows the geographic impact of William E. P. Renwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. P. Renwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. P. Renwick more than expected).
Fields of papers citing papers by William E. P. Renwick
This network shows the impact of papers produced by William E. P. Renwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. P. Renwick. The network helps show where William E. P. Renwick may publish in the future.
Co-authors
The 25 scholars most cited alongside William E. P. Renwick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 561 |
| 2 | 2019 | 183 | |
| 3 | 2010 | 123 | |
| 4 | 2006 | 50 | |
| 5 | 2009 | 46 | |
| 6 | 2016 | 44 | |
| 7 | 2020 | 32 | |
| 8 | 2014 | 16 | |
| 9 | 2015 | 16 | |
| 10 | 2023 | 13 | |
| 11 | 2012 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2013 | 8 | |
| 14 | 2015 | 7 | |
| 15 | 2010 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2011 | 1 |
About William E. P. Renwick
William E. P. Renwick is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Biochemistry, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers), Neutropenia and Cancer Infections (2 papers), Lung Cancer Diagnosis and Treatment (1 paper), Blood transfusion and management (1 paper) and Lymphadenopathy Diagnosis and Analysis (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (467 citations), Hematology (251 citations), Geriatrics and Gerontology (27 citations), Biochemistry (44 citations) and Genetics (44 citations). William E. P. Renwick has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Alpha E. Tsui, Sant‐Rayn Pasricha, Daniel Steinfort, Matthew Conron, Louis B. Irving, Phillip N. Antippa, Ruth Pettengell, James Tatoulis, Christopher Hogan and Michael Haeusler. Their work appears in journals such as Blood, Leukemia, The Lancet, BioDrugs and The Annals of Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.